#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer recurrent Langerhans cell sarcoma Gaucher's disease type III Fibrodysplasia ossificans progressiva Deafness neurosensory NTRK gene fusion overexpression Neuroendocrine tumour of the lung Chronic graft versus host disease in intestine Depression Cataract Diffuse large B-cell lymphoma Phaeochromocytoma Nephropathy Transient ischaemic attack Hairy cell leukaemia recurrent More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Basic Information Mucopolysaccharidosis I Nephroblastoma – Life with Disease Netherton’s syndrome Propionic acidaemia – Diagnostics Focal segmental glomerulosclerosis – Treatment Mucopolysaccharidosis II – Diagnostics Waldenstrom’s macroglobulinaemia – Treatment Arterial tortuosity syndrome – Trials in Disease MELAS syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlortalidone Bevacizumab Dermatophagoides Farinae Cpk850 LY3848575 Ceftazidime Pentahydrate Dextromethorphan Hydrobromide Op-1250 Catequentinib Dihydrochloride Gentamicin Tipranavir OMECAMTIV MECARBIL Tenecteplase Incb099280 Sodium Butyrate Hydroxyzine Hydrochloride Ripretinib LTX-002 SODIUM Mosaic Hbcoreag Ddcart‐Cd19 More therapies…

    Learn about Your Condition

    Breast cancer stage III Brain stem glioma Tricuspid valve disease Immune-mediated enterocolitis Primary hypogonadism Acquired haemophilia Intellectual disability End stage renal disease Metastases to meninges Arterial disorder Hyponatraemia Facial paresis Deafness traumatic Dilated cardiomyopathy Peripheral artery angioplasty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Clemizole Hydrochloride for Children and Adults with Dravet Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Clemizole Hydrochloride
    Hungary Poland Spain

  • Study on Cetuximab-Based Treatment for Metastatic Colorectal Cancer in Patients with RAS/BRAF Wild Type Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Fluorouracil Sodium
    Italy

  • Study on Antibiotic Levels in Blood of Pregnant Women with Twins Using Piperacillin, Tazobactam, Cefazolin, Ampicillin Sodium, and Clindamycin

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefazolin
    • Piperacillin
    • Clindamycin
    Austria

  • Study Comparing Docetaxel and Androgen Receptor-Targeted Agents (Abiraterone or Enzalutamide) for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone
    • Docetaxel
    • Enzalutamide
    Italy

  • Study on Preventing Respiratory Infections and Wheezing in Late-Moderate Preterm Infants Using Bacterial Lysates

    Recruiting

    3 1 1 1
    The Netherlands

  • Study on the Use of Alteplase and Andexanet Alfa for Patients with Acute Ischemic Stroke on Non-Vitamin K Oral Anticoagulants

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Andexanet Alfa
    • Alteplase
    Poland
Previous Page
1 … 295 296 297 298 299 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!